OneThree Biotech

📍 New York, United States🗓 Founded 2018👥 4 employees
Biotechnology Research🌐 onethree.bio
Website LinkedIn
OneThree Biotech was born out of the largest precision medicine institute in America with the purpose of decreasing the failure rate of bringing therapeutics to market using biology driven artificial intelligence. Our technology was built in a lab setting; allowing us to engineer our methodologies around real-world results. While working with major biotech and pharma partners; we’ve validated our predictions through work in target discovery, compound and combination therapy identification, toxicity prediction, biomarker selection, and much more. Our predictions have been validated with partners such as AstraZeneca, Jubilant, and more. For example, we predicted the top indication, and mechanism of action for Oncoceutics asset ONC201 which was subsequently validated in a Phase II trial.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was OneThree Biotech founded?
OneThree Biotech was founded in 2018.
What industry is OneThree Biotech in?
OneThree Biotech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is OneThree Biotech based?
OneThree Biotech is headquartered in New York, United States.